The Department of Health and Human Services is aware of 20 pharmaceutical products made or with a critical active ingredient solely sourced in China, but to date is not aware of any expected shortages, HHS Secretary Alex Azar told House appropriators today. He said the agency knows of two pharmaceutical makers in Hubei Province, the epicenter of the novel coronavirus (COVID-19) outbreak, but they have a large stockpile supply of advance production.

For the first time since the outbreak started, more new cases are being reported outside China than from China, the World Health Organization said today. While China continues to have the most cases overall, there are now confirmed COVID-19 cases on every continent except Antarctica, totaling more than 81,000 in 37 countries.

The Centers for Disease Control and Prevention continues to update resources, including interim guidance for businesses and employers to plan and respond to COVID-19.

For the latest information and resources, visit AHA’s coronavirus webpage.

Related News Articles

Headline
The Centers for Disease Control and Prevention yesterday updated its infection prevention and control guidance for health care facilities, and posted a form…
Headline
The Centers for Medicare & Medicaid Services yesterday released COVID-19 infection control guidance for Programs of All-Inclusive Care for the Elderly…
Headline
White House Meeting. AHA President and CEO Rick Pollack and hospital and health system leaders today met with top Administration officials at the White House…
Headline
Centers for Disease Control and Prevention Director Robert Redfield today said the agency is in the process of setting up a public tracker for novel…
Headline
The Centers for Disease Control and Prevention over the weekend updated its guidance for evaluating and testing patients for novel coronavirus (COVID-19), and…
Headline
America’s Health Insurance Plans yesterday said it is taking action to make sure plans cover COVID-19 diagnostic testing and reduce service barriers, such…